AGP Executive Report
Last update: 7 hours agoFake medicines alarm: Pharmacy and Poisons Board investigations warn of falsified medical products and faulty HIV test kits circulating in Kenya, including ARVs, Viagra, rapid HIV kits and dialysis-related blood thinners—raising fears of treatment failure and preventable deaths. Menstrual health push: Government says Kenya must invest more in the menstrual health sector, framing it as an economic opportunity that can create jobs across manufacturing, logistics and waste management. GBV spotlight in Teso North: Officials report rising gender-based violence, urging couples to use dialogue and report abuse early through community structures like Nyumba Kumi. HIV care and trust: A feature revisits how Kenya’s public health messaging has often relied on fear during outbreaks, arguing it can fuel stigma and weaken trust. Health workforce and training: KMTC launches a multi-agency interoperability eLearning programme to improve coordinated emergency response. Reproductive health jobs: ICRH-Kenya advertises 27 resident enumerator roles for KCSE C+ holders in Meru and Tharaka Nithi. Policy and access: Finance Act 2026 keeps the current tax treatment for person-to-person digital transfers for chamas, after MPs dropped a proposed VAT. Ebola preparedness debate: Another report looks at how Kenya fights epidemics without winning public trust.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.